Carnegie Investment Counsel’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
2,753
-148
-5% -$25.2K 0.01% 412
2026
Q1
$522K Buy
2,901
+148
+5% +$29.4K 0.01% 409
2025
Q4
$597K Hold
2,753
– – 0.01% 381
2025
Q3
$706K Hold
2,753
– – 0.01% 354
2025
Q2
$714K Hold
2,753
– – 0.01% 339
2025
Q1
$671K Buy
+2,753
New +$692K 0.02% 333
2019
Q2
– Sell
-2,277
Closed -$270K – 426
2019
Q1
$270K Hold
2,277
– – 0.02% 359
2018
Q4
$212K Buy
+2,277
New +$242K 0.02% 347
2018
Q3
– Sell
-2,251
Closed -$292K – 354
2018
Q2
$292K Hold
2,251
– – 0.02% 322
2018
Q1
$258K Hold
2,251
– – 0.02% 324
2017
Q4
$265K Hold
2,251
– – 0.02% 337
2017
Q3
$246K Buy
2,251
+26
+1% +$3.44K 0.03% 316
2017
Q2
$324K Hold
2,225
– – 0.04% 287
2017
Q1
$302K Buy
+2,225
New +$283K 0.04% 287

Other funds holding EFX

Carnegie Investment Counsel's EFX Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Equifax (EFX) stake by 5.1% in Q2 2026, selling an estimated $25.2K and leaving 2,753 shares worth $437K. The position accounts for 0.01% of the portfolio, ranked #412.

Carnegie Investment Counsel first reported a position in EFX in Q1 2017 and has held it in 14 quarters since. The position peaked at $714K in Q2 2025. 838 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Carnegie Investment Counsel held 2,753 shares of Equifax worth $437K as of Q2 2026.
  • Carnegie Investment Counsel sold 148 Equifax shares in Q2 2026, an estimated $25.2K.
  • Equifax made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #412 holding.
  • Carnegie Investment Counsel first reported a position in Equifax in Q1 2017 and has held it in 14 quarters since.
  • Carnegie Investment Counsel's Equifax position peaked at $714K in Q2 2025.
  • 838 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.